Durata Therapeutics, Inc.
CIK 0001544116
Revenue (TTM)
—
Q3 Oct 2014
Net Income (TTM)
−$69.86M
−31.4% YoY
Q3 Oct 2014
EPS Diluted (TTM)
—
Q3 Oct 2014
Gross Margin
—
Q3 Oct 2014
Operating Margin
—
Q3 Oct 2014
Net Margin
—
Q3 Oct 2014
Free Cash Flow (TTM)
—
Q3 Oct 2014
Cash
$27.67M
Q3 Oct 2014
Total Debt
$65M
Q3 Oct 2014
Shares Outstanding
26.79M sh
Q3 Oct 2014
Revenue & Net Income
Revenue Growth (YoY)
No data available for this metric.